chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Gush of blood after period ended/it was fresh red blood with some small clots; This is a spontaneous report from a contactable consumer (patient). A 54-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0176; Expiration Date: Aug2021), dose 2 via an unspecified route of administration, administered in Arm Left on 28Apr2021 08:45 as DOSE 2, SINGLE for covid-19 immunisation (at the age of 54-years). Medical history included asthma (caller has had since she was three years old), crohn's disease (diagnosed in '89, caller states so about 23) and blood pressure measurement. Concomitant medication included losartan (LOSARTAN) (caller has been on for about probably 14-15 years). The patient previously took first dose at the same place, at 8:45 am in her upper left shoulder (LOT number: ER8734, expiration date: Jul2021). Adverse events following prior vaccinations: none that she knows of, she has not had vaccines at all, and has not had a flu shot. To her knowledge, she has never had a pneumonia shot. Other than that, her only vaccines were when she was a kid. The patient experienced gush of blood after period ended/it was fresh red blood with some small clots (she thinks she is perimenopausal where her period is every 6 months or so. Her period started last Tuesday and was normal. She normally does not have any troubles. Yesterday, caller states she had no flow. Today, this morning, none. She did not have a pad. She felt fine and felt good. Around 12 o'clock, she was standing up doing work for her job. She had a gush of blood. She had to sit on the toilet until her husband came home. It just gushed. Caller added it was fresh red blood with some small clots and that it is still pouring. She has a pad on now, but it is still pouring as she speaks.) on 06May2021. The patient did not visited physician office and emergency room. The outcome of the event was not recovered.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a medical assistant refers to a patient of unknown age. On 06-SEP-2016, the patient was vaccinated with the first dose of VARIVAX (dose, route and indication were not reported, lot # M010481 with expiration date: 01-MAR-2018). On 08-SEP-2016, the patient received a second dose of VARIVAX (dose, route and indication were not reported, lot # M010481 with expiration date: 01-MAR-2018). No adverse events reported. Additional information has been requested.
swollen lymph glands/lymph nodes on the throat; This is a spontaneous report received from a contactable reporter, Consumer, from medical information team. The reporter is the patient.  A 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 13Feb2021 (Batch/Lot number: unknown) at the age of 69 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 20Feb2021, outcome "unknown", described as "swollen lymph glands/lymph nodes on the throat". Additional information: Got Pfizer 1st dose on 13Feb2021. A week later started developing swollen lymph glands mainly on the side of the injection site and a bit the other side. The patient stated that it was not at the injection site but the lymph nodes on the throat.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
neurological episodes causing headaches, dizziness and balance problems; neurological episodes causing headaches, dizziness and balance problems; neurological episodes causing headaches, dizziness and balance problems; neurological episodes causing headaches, dizziness and balance problems; an outbreak of a painful rash resulting in chronic, sensitive skin on her spine and back and across her shoulder blade and underneath her harm, as well as severe fatigue/ diagnosed with shingles (herpes zoster); Information has been received from a lawyer regarding a case in litigation concerning a female patient(pt) of unknown age. The pt's medical history, concurrent conditions and concomitant medications were not provided. On 02-AUG-2017, the pt was inoculated with zoster vaccine live(ZOSTAVAX) at a pharmacy for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). After approximately then days of receiving zoster vaccine live(ZOSTAVAX), the pt suffered debilitating injuries including an outbreak of a painful rash resulting in chronic, sensitive skin on her spine and back and across her shoulder blade and underneath her harm, as well as severe fatigue. On 22-AUG-2017, the pt was diagnosed with shingles (herpes zoster) which had resulted in subsequent outbreaks since the initial diagnosis, all as a result of zoster vaccine live(ZOSTAVAX). Since these initial injuries manifested, the pt experienced frequent neurological episodes causing headaches, dizziness and balance problems. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), the pt's symptoms had resulted in physical limitations not present prior to using zoster vaccine live(ZOSTAVAX) and caused by the zoster vaccine live(ZOSTAVAX). As a result of zoster vaccine live(ZOSTAVAX), the pt sustained severe and disfiguring personal injuries. Further, as a tragic consequence, the pt suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.
Itchy red lump about 2 inches in diameter appeared a week after injection. It is very hard to the touch and noticeably raised. Online search says it is ?Covid arm?.
This case was reported by a consumer via interactive digital media Facebook post and described the occurrence of adverse event in a female patient who received DTP (A or W not known) (DTP (A or W not known)) for prophylaxis. On an unknown date, the patient received DTP (A or W not known) at an unknown dose. On an unknown date, unknown after receiving DTP (A or W not known), the patient experienced adverse event (serious criteria death). On an unknown date, the outcome of the adverse event was fatal. The reported cause of death was adverse event. It was unknown if the reporter considered the adverse event to be related to DTP (A or W not known). Additional details were provided as follows: This case was received via social media post contents by the patient's mother.  The patient's family had no issues in the past with the shot and thought by getting it could protect the daughter from getting it from him but unfortunately that's the very thing that caused her granddaughter to have hospitalized. It was not fun but she was alive and happy with no brain damage. The age at vaccination was not reported. The reporter stated that the patient died from a reaction to the DPT vaccine. It was unknown if an autopsy was performed or not. This case was linked with case US2018GSK219962, reported by the same reporter.; Reported Cause(s) of Death: adverse event.
In late October I began experiencing pain in my right leg after walking for no more than 15min. I went to the Dr. on 11/2/2021. Dr. found a lump in my leg. After testing they found a thrombosis clot in my upper thigh of my right leg. I was RX'd Eliquis for 3 months. I was recommended to a hematologists whom I saw on 12/28.
Mother of child reports that child had redness, swelling and warmth at injection site within only a few minutes (<30). Site remained tender to touch until present and is still swollen with a centralized knot. He also has a blister like rash on left hand and in scalp.
had afib ablation 3 yrs ago with no indications of recurring until the day after receiving this vaccine. heartrate has been around 60 since ablation and pacemaker installed, now since shot, between 85-105. I have had dizziness, no energy, pain in chest and left shoulder, nausea, vomiting, fall, chills, no appetite, no energy, and unsteady. I am writing this 5 days after shot and still have effects.
Narrative:  Admitted: JAN 8,2022 Discharged: Jan 14,2022 85 y/o M with PMH BPH, HLD, HTN, dementia, insomnia, b/l hearing loss, CKD, COPD (2018 via CT w/ emphysema), seizure, stroke/meningioma, blind secondary to glaucoma and cataracts presented to the Emergency Department with altered mental status, acute hypoxic respiratory failure, COVID+ despite vaccination x 2 and required ICU care. #Acute hypoxic respiratory failure, Covid positive, h/o COPD (improving): On admission on 1/8/22 patient tested positive for COVID and was febrile with a procalcitonin of 4. Patient initially requiring 4 L nasal cannula in ED. Started on CAP coverage in ED, ceftriaxone and azithromycin. Given concern for sepsis, patient required ICU care. He was broadened out from CAP to Vanc/Zosyn; Remdesevir, Dexamethasone 6mg daily. Infectious workup done and was negative aside from pulmonary source. Patient showed improvement with downtrend in lactate and was weaned to Room Air. He was then transferred to floor and transitioned back to ceftriaxone and azithromycin. He completed 7 day course of antibiotics, 5 days of remdesivir, and 10 days of dexamethsone 6mg daily. Discharged in stable condition.
After receiving the Anthrax vaccination, I experienced headaches, neck stiffness and pain for 1 week.  I experienced localized and neck swelling for 3-4 days.
On March 29, 2023, I began having symptoms of overwhelming fatigue. I had pressure in my throat which made it difficult for me to talk. I had a mild headache and some digestion issues. I did not have fever. They symptoms lasted about 3-4 days. I contacted the doctor on April 2, 2023, and began taking PAXLOVID on April 4, 2023. As of today, I feel like I just have a lingering cough.
Patient presented to the ED and was subsequently hospitalized for hyperkalemia within 6 weeks of receiving covid vaccination.
Pain at the injection site upon injection that increased over time, eventually with swelling and redness. Starting the following day I developed a headache and had an increased temperature, eventually a fever reaching 100.7 F. Temperature has returned to normal the following day. Pain at the injection site persists.
(L) deltoid with 7.5 cm x 6 cm area redness and warmth. (L) deltoid sore, unable to fully raise arm.
Information has been received from a registered nurse concerning an 11 year old male with asthma, a amoxicillin allergy and a history of pneumonia, who on 05 APR 2005 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine.  Concomitant therapy included CLARINEX, MSD, ADVAIR, XOPENEX, and FULMICORT.  On 07 APR 2005 it was noted that the patient had been place on therapy PREVACID.  On 07 APR 2005, it was reported by the patient's mother that the patient's right arm was sore and he was "feverish and achy".  It was also reported that he was treated with TYLENOL or ADVIL and cold compresses.  Unspecified medical attention was sought.  No diagnostic studies were performed.  The patient's outcome was unknown.  No product quality complaint was involved.    Additional information was requested.    It was also reported that an additional patient was vaccinated with a dose of PPV and experienced adverse events.
they were concerned about blood clot; shaking uncontrollably; pouring sweat; sheet white with no color to skin at all; blood pressure 68/30; not particularly coherent; This is a spontaneous report received from a contactable consumer (patient's husband). A female patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route on an unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The reporter stated his wife had adverse event to the COVID vaccine last week. He stated that they both got the vaccine. At 3 AM on unspecified date, the reporter woke up because his wife (patient) was shaking uncontrollably, pouring sweat, sheet white no color to skin at all, not particularly coherent and had blood pressure 68/30. They had to call an ambulance and she was brought to the hospital. They were able to get her blood pressure up and stabilized her after 8 hours. They were concerned about blood clot and did other scans. Lab data included blood pressure 68/30 (units unspecified) and scans with unknown results; both on unspecified date. The clinical outcomes of shaking uncontrollably, pouring sweat, sheet white no color to skin at all, not particularly coherent and blood clot were unknown, while of blood pressure 68/30 was recovering.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Cranky & clingy, no appetite, fever 102 on the night of the vaccine (which was Thursday). On Friday, his fever was lower (99) in the morning, but still very little appetite and cranky.  Later in the morning, he seemed normal again, but around lunch time still no appetite, fever returned and very tired.  After nap, he seemed normal again.  At supper, he didn't want to eat and got cranky again.  Normally, he sleeps fine through the night, but he woke up several times during the night crying out.  Now it is Saturday morning.  So far he seems okay.  I have been giving him Advil and applying lemon essential oil to his spine and lavender essential oil to the bottom of his feet.
Fever over 100 degrees F / Headaches/ Chills / Muscle Aches /  Fell on the ground on 8/8/23 at 8:45pm after trying to get something from the Kitchen. May have hit my head on ground unsure due to the side effects. I did not seek medical help as felt fine.
pt states no symptoms until 1/29 pt stated she woke up w/ fever and did not feel.  Pt called her PCP and spoke to the nurse and was told to rest and drink fluids and call if symptoms got worse.
I had pain in the heart, pain at neck and also pain near spine. I used hot pack relax the pain in the neck but till today i have the pain
pt recv vax;local rxn,tenderness,swelling,fever & d;to MD;tx w/ atb;
New medication for seizure (mild-mod) petit mal seizure activity started at 14:05 Vital Signs: BP 118/84 HR 87 Resp 20 O2sat 99  Skin Signs: Warm and dry  Circulation: Cap refill <2sec  Respiratory: Breath sound clear bilaterally  Refused to lie on cot. Seizure activity is common patient states with loud noises. 14:14 without seizure activity, breath sounds clear, speech clear  14:20  Vital Signs: BP 122/86 HR 88 Resp 20 O2sat 97 Skin Signs: Warm and dry  Circulation: Cap refill <2sec  Respiratory: Breath sound clear bilaterally  Assess by  MD  Maintain quiet environment at home this afternoon and pm  Disposition: Home with family
subcutaneous administration instead of intramuscular; This non-serious case was reported by a other health professional via call center representative and described the occurrence of intramuscular formulation administered by other route in a 30-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number B4C44, expiry date 10-NOV-2024) for prophylaxis.   On 23-FEB-2023, the patient received Boostrix (subcutaneous). On 23-FEB-2023, an unknown time after receiving Boostrix, the patient experienced intramuscular formulation administered by other route (Verbatim: subcutaneous administration instead of intramuscular). The outcome of the intramuscular formulation administered by other route was unknown.   Additional Information: GSK Receipt Date: 06-MAR-2023 The reporter was a healthcare professional. The reporter reported that the patient administered Boostrix vaccine subcutaneously instead of intramuscular route. The reporter did consent to follow up. The patient received Boostrix vaccine was given subcutaneous instead of intramuscular, which led to intramuscular formulation administered by other route
Patient reported nausea vomiting dizziness and headache. She said these symptoms started about 5 and half hours after the vaccine administration. I spoke to her physician's office listed above and the nurse recommended fluids and rest. We are still waiting to follow up. Instructed pt that if symptoms get worse or do not improve in 24 hours to seek medical attention.
Soreness at injection site; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via unspecified route of administration on left arm on 25Mar2021 at 10:30 (at the age of 53 years old) as a single dose, for COVID-19 immunisation. Medical history included thyroid disorder, asthma and depression. The patient was allergic to penicillin and metronidazole(FLAGYL) from an unspecified date. Concomitant medication included bupropion hydrochloride (WELLBUTRIN), clarithromycin (MANUFACTURER UNKNOWN), levothyroxine sodium (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN) from an unspecified date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021, at 12:00, the patient experienced soreness at injection site (vaccination site pain). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. No treatment  was taken in response to the event. The clinical outcome of the event vaccination site pain was not recovered at the time of the report.   No follow-up attempts are possible; information about lot number cannot be obtained.
Admitted for weakness, confusion and dyspnea on 05/05/21; PMhx of CAD , HTN, DMNID, Hypothyroidism; discharged 5/10/2021.
Information has been received from a medical assistant concerning a 46 year old male patient who on 26-FEB-2010 was vaccinated with an IM 0.5 ml dose of PNEUMOVAX 23 (Lot # 664864/1365Y) in his left arm. On 26-FEB-2010, after PNEUMOVAX 23 was given, the patient developed cellulitis. The patient also had redness at the injection site and swollen lymph nodes under the left arm. The patient sought medical attention by an office visit. At the time of the report, the patient was recovering. Follow up information has been received from a medical assistant who indicated that the patient with asthma (FG/mild BPH) on 26-FEB-2010 at 11:15 a.m. was vaccinated with a dose of PNEUMOVAX 23 in his left upper arm. The next day following vaccination (reported as 26-FEB-2010) the patient developed cellulitis. The patient had to go to a clinic where received antibiotics and unspecified (illegible) treatment. The patient was clinically evaluated and had a follow-up visit with a physician. On approximately 01-MAR-2010, the first week of March 2010, the patient recovered from cellulitis. Cellulitis was considered to be disabling and other important medical event by the reporter. Additional information is not expected.
It started out six or seven days after my vaccine a light irritation that was itchy on my chest not raised but subdermal like little dots ugly rash as the days went on more appeared and filled in that became a fine textured rash that itched like crazy all the topical treatments tried did not work I took cold shower and the dermatologist suggested a bleach like bath. Two ointments were prescribed; triamcinolone acetonide ointment and clobetasol propionate.
no adverse event; a patient was administered improperly stored Vaqta; This spontaneous report as received from a medical assistant refers to a 4-year-old patient of unknown gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 27-SEP-2019, the patient was vaccinated with improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) (lot number: S007770, expiration date: 24-JUL-2020; dose and route of administration were not provided). The vaccine was stored at temperature below 36 degrees Fahrenheit (2 degrees Celsius, 35.4 degrees Fahrenheit) for 10 minutes. There was no previous temperature excursion. Digital data lodger was not involved. No adverse event was reported.
I started experiencing allergic reaction to all of my facial/body topical products on 2/3/21. I break out in hives/swelling/ redness/ itching at site and some times burning and swelling/hives around my eyes and throat. I have been just taking Benadryl, which does take away the symptoms within a couple hours.
Extreme nausea, vomiting, GI Pain, even worse with the second dose to the point I had to go to the ER for fluids and IV nausea and vomiting meds
Patient presented with erythematous rash with occasional vesicular blisters over upper chest, bilateral arms, and upper back. Rash was not present on the lower body. Patient complained of itching and burning sensation.
Shortness of breath, burning/watery eyes, muscle spasm, disoriented, sore throat, tightening of throat